NDC 70771-1682

LACOSAMIDE

Lacosamide

LACOSAMIDE is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Zydus Lifesciences Limited. The primary component is Lacosamide.

Product ID70771-1682_2e8b7789-c673-4f02-b73b-bd465c71c7f5
NDC70771-1682
Product TypeHuman Prescription Drug
Proprietary NameLACOSAMIDE
Generic NameLacosamide
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-06-29
Marketing CategoryANDA /
Application NumberANDA209465
Labeler NameZydus Lifesciences Limited
Substance NameLACOSAMIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE]
DEA ScheduleCV
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70771-1682-6

10 VIAL in 1 CARTON (70771-1682-6) > 20 mL in 1 VIAL (70771-1682-1)
Marketing Start Date2022-06-29
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LACOSAMIDE" or generic name "Lacosamide"

NDCBrand NameGeneric Name
0121-0992LacosamideLacosamide
0121-1984LacosamideLacosamide
0121-2976LacosamideLacosamide
0121-3968LacosamideLacosamide
63850-0055LacosamideLacosamide
63850-0053LacosamideLacosamide
63850-0054LacosamideLacosamide
63850-0056LacosamideLacosamide
65162-912LacosamideLacosamide
0131-1810Vimpatlacosamide
0131-2470Vimpatlacosamide
0131-2477Vimpatlacosamide
0131-2478Vimpatlacosamide
0131-2479Vimpatlacosamide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.